OH2 injection: Clinical Trials

6 trials of OH2 injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 recruiting, 1 unknown. 6 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 2, Terminated 2, Recruiting 1, Unknown 1
Phase 15Completed 2, Recruiting 1, Terminated 1, Unknown 1

Follow OH2 injection: new trials by email Literature Review of OH2 injection trials Research Report on OH2 injection

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
OH2 injection - Non-muscle-invasive Bladder Cancer
Phase 1 / Phase 2UnknownBinhui Biopharmaceutical Co., Ltd.302022-07-112024-08-12
OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer
OH2 injection - Advanced Bladder Carcinoma
Phase 2TerminatedBinhui Biopharmaceutical Co., Ltd.42022-05-252025-08-03
OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
OH2 injection - Central Nervous System Tumors
Phase 1 / Phase 2CompletedBinhui Biopharmaceutical Co., Ltd.402021-11-162026-08-05
OH2 Oncolytic Viral Therapy in Pancreatic Cancer
OH2 injection - Pancreatic Cancer
Phase 1 / Phase 2TerminatedBinhui Biopharmaceutical Co., Ltd.52021-02-022023-11-24
OH2 Injection in Combination With HX008 for Melanoma.
OH2 injection, HX008 injection - Melanoma
Phase 1 / Phase 2RecruitingBinhui Biopharmaceutical Co., Ltd.602020-12-012025-07-24
OH2 Injection in Solid Tumors
OH2 injection, Keytruda - Solid Tumor, Melanoma
Phase 1 / Phase 2CompletedBinhui Biopharmaceutical Co., Ltd.442018-11-222026-08-06

Conditions studied

Melanoma (2)  ·  Central Nervous System Neoplasms (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Binhui Biopharmaceutical Co., Ltd. (6)

Countries

China (6)

Results publications

PMID 38537773, PMID 39915002